Daptomycin Injection, Powder, Lyophilized, For Suspension
Product Images NDC 83090-011

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Daptomycin (NDC 83090-011). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sintetica Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Image 01)

Chemical structure diagram of daptomycin, showing its cyclic peptide molecular configuration with various amino acid residues and side chains clearly depicted.*

FDA Label Image

Vial-10000007001 (Image 02)

Label for daptomycin injection 500 mg per vial, lyophilized powder for intravenous infusion. The label highlights that the product must be refrigerated and is for single-dose vial use. It is distributed by Sintetica US LLC, with storage instructions specifying use of 0.9% sodium chloride injection for reconstitution.*

FDA Label Image

Carton-10000007001 (Image 03)

Packaging label for daptomycin for injection, 500 mg per vial, lyophilized powder for suspension. The label indicates it must be refrigerated and includes directions for intravenous infusion with 0.9% Sodium Chloride Injection for reconstitution. Manufactured by Hainan Poly Pharm Co., Ltd. and distributed by Sintetica US LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.